PartnershipJul 7, 2026, 08:12 AM
Silo Pharma's QwikAgents Joins NVIDIA Developer Program
AI Summary
Silo Pharma announced that its wholly owned subsidiary, QwikAgents, has joined the NVIDIA Developer Program. This move is expected to enhance and advance QwikAgents' AI agent integration platform, which is designed to automate complex workflows using autonomous AI agents. Joining the program provides QwikAgents with access to NVIDIA's AI software ecosystem, development frameworks, and optimization resources, aiming to accelerate platform innovation for enterprise customers.
Key Highlights
- Silo Pharma's wholly owned subsidiary, QwikAgents, joined the NVIDIA Developer Program.
- The program provides QwikAgents access to NVIDIA's AI software ecosystem, development frameworks, and resources.
- This partnership is expected to enhance and advance QwikAgents' AI agent integration platform.
- QwikAgents' platform automates complex workflows using autonomous AI agents.
- Silo Pharma is a developmental-stage biopharmaceutical company focused on underserved conditions.
Price Impact
More from SILO